Titan Biotech Ltd Share Price

Q: What is the share price of Titan Biotech Ltd today?

Titan Biotech Ltd share price as on 18 Jul 2026 is ₹436.5

Pharmaceuticals

BSE: 524717 Small Cap ISIN: INE150C01029

As on 18 July 2026 at 09:10 IST

₹436.50

-5.90

(-1.33%)

Sell Buy

Over 1 Month

-4.28%

Over 6 Months

113.49%

Over 1 Year

412.45%

Over 3 Years

736.93%

Titan Biotech Ltd Summary

Close ₹442.40

Open ₹439.20

High ₹455

Low ₹430.65

Volume 23,119

Net Turnover (in Cr) ₹1.03

52Wk High ₹555.65

52Wk Low ₹74.73

52Wk High / Low

74.73

555.65

Titan Biotech Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,827.93

EPS (TTM) 6.64

Book Value (BV) 41.35

Div. Yield 0.11 %

P/E (TTM) 66.63

Price/Book Value 10.70

Delivery % 100 %

Face Value 2

Key Ratios

PE Ratio 19.07

PB Ratio 2.40

EV to Sales 2.21

PEG Ratio -0.84

ROA 12.22

ROE 13.36

Debt-Equity 0.04

Net Profit Margin 11.68

Operating Profit Margin 18.75

Titan Biotech Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	160.36	165.82	145.94	124.49	143.03
Total Expenses	136	134.29	117.83	95.52	100
Profit Before Tax	24.37	31.53	28.12	28.97	42.71
Profit After Tax	18.27	23.66	21.02	21.68	31.71
Operating Profit After Depreciation	25.17	32.70	28.86	29.84	44.70

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	57.28	52.03	35.89	34.99	33.61
Total Non Current Assets	95.67	84.41	66.21	44.34	41.89
Total Current Assets	79.04	72.62	68.31	63.76	58.83
Total Assets	174.71	157.03	134.52	108.09	100.72
Total Shareholder's Fund	153.40	133.45	109.91	86.24	68.76

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	20.12	21.15	21.18	22.04	19.08
Net Cash Used In Investing Activities	-9.87	-20.30	-20.73	-16.44	-4.86
Net Cash Used In Financing Activities	-7.96	-2.87	-2.40	-4.10	-10.60

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	160.36	165.82	145.94	124.49	123.12
Total Expenses	136	134.29	117.83	95.52	84.03
Profit Before Tax	24.37	31.53	28.12	28.97	38.76
Profit After Tax	18.27	23.66	21.02	21.68	28.77
Operating Profit After Depreciation	25.17	32.70	28.86	29.84	40.36

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	57.28	52.03	35.89	34.99	27.04
Total Non Current Assets	87.40	79.40	62.39	44.34	36.54
Total Current Assets	79.04	72.17	68.31	63.76	49.63
Total Assets	166.44	151.57	130.70	108.09	86.17
Total Shareholder's Fund	145.13	128.44	106.09	86.24	65.82

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	20.12	21.15	21.18	22.04	17.59
Net Cash Used In Investing Activities	-9.87	-20.30	-20.73	-16.44	-4.17
Net Cash Used In Financing Activities	-7.96	-2.87	-2.40	-4.10	-9.81

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	48.83	56.51	54.35	46.50	35.17
Total Expenses	39.12	45.67	45.03	37.76	30.60
Profit Before Tax	10.28	10.57	9.21	8.11	5.03
Profit After Tax	6.56	7.87	6.86	6.16	3.77
Operating Profit after Depreciation	11.82	12.10	10.64	9.46	5.95

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	48.83	56.51	54.35	46.50	35.17
Total Expenses	39.12	45.67	45.03	37.76	30.60
Profit Before Tax	10.28	10.57	9.21	8.11	5.03
Profit After Tax	6.56	7.87	6.86	6.16	3.77
Operating Profit after Depreciation	11.82	12.10	10.64	9.46	5.95

Titan Biotech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 430.37

S2 418.33

S3 406.02

Pivot 442.68

R1 454.72

R2 467.03

R3 479.07

Moving Average

20 SMA 444.21

50 SMA 459.68

100 SMA 361.90

200 SMA 277.52

Titan Biotech Ltd Corporate Actions

Titan Biotech Ltd

₹2.0/Share

Announcement Date 19 Sep 2025

Record Date 19 Sep 2025

Div Yield 20%

AGM Date: 24 Sep 2021

Record Date has been fixed for the purpose of AGM and payment of dividend subject to approval of shareholders in the AGM scheduled on 24-09-2021. Corporate Action Book Closure of Share Transfer Books and Register of Members for the purpose of AGM and payment of Dividend subject to approval of Shareholders in General Meeting scheduled on 24-09-2021. (As Per BSE Announcement Dated on 25.08.2021) Brief Proceedings of Annual General Meeting of Company held on 24th September 2021 at 3.00 P.M.(As Per BSE Announcement Dated on 9/25/2021 12:22:42 PM) Declaration of Results of AGM by the Chairman of the meeting for AGM held on 24-09-2021 alongwith Scrutiniser Report.(As Per BSE Announcement Dated on 9/25/2021 5:41:33 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Unaudited Financial Results for quarter ended 30/06/2022 (As Per BSE Announcement dated on 10.08.2022) Filling of casual vacancy of Statutory Auditor at Board Meeting (As Per BSE Announcement Dated on 26.08.2022) Submission of Newspaper advertisement about the notice of Annual General Meeting 30th Annual Report of Titan Biotech Limited (As Per BSE Announcement Dated on 31/08/2022) Proceedings of AGM held on 30.09.2022 (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 29 Sep 2023

31st Annual General Meeting of Shareholders scheduled on 29th September, 2023 as per Notice of AGM being circulated shortly. Book Closure for AGM and Dividend 23.09.2023 (Saturday) to 29-09-2023 (Friday). Proceeding of 31st AGM of Company. (As Per BSE Announcement dated on 29.09.2023) Voting Results and Scrutiniser Report for AGM 2023 (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 30 Sep 2024

Submission of Publication of Newspaper Advertisement for The 32nd Annual General Meeting PROCEEDING OF 32ND AGM (As Per Bse Announcement Dated on 30.09.2024)

AGM Date: 26 Sep 2025

AGM 26/09/2025 Please be informed that the Thirty-Third (33rd) Annual General Meeting ('AGM') of the Company has been scheduled for Friday, September 26, 2025, through Video Conferencing ('VC')/Other AudioVisual Means ('OAVM'). Proceedings of Thirty Third Annual General Meeting. (As Per BSE Announcement Dated on:26.09.2025) Summary of Proceedings of Thirty Third (33rd) AGM of the Company along with Voting Results and Scrutinizers Report. (As Per BSE Announcement Dated on: 27/09/2025)

Titan Biotech Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Titan Biotech Ltd Top Mutal Funds Invested

No data available

Titan Biotech Ltd News

Board of Titan Biotech recommends final dividend

Of Rs 0.5 per share

01 Jun 2026, 11:01 am

Titan Biotech to hold board meeting

On 30 May 2026

21 May 2026, 03:26 pm

Titan Biotech to table results

On 12 February 2026

04 Feb 2026, 10:52 am

Titan Biotech to conduct board meeting

On 29 November 2025

25 Nov 2025, 05:31 pm

Titan Biotech announces board meeting date

On 11 November 2025

05 Nov 2025, 12:42 pm

Titan Biotech Ltd Stock Analysis

Annual revenue for Titan Biotech Ltd decreased by 3.29% to ₹160.36 crore in FY 2025 from ₹165.82 crore in FY 2024.
Annual Net Profit for Titan Biotech Ltd decreased by 22.79% to ₹18.27 crore in FY 2025 from ₹23.66 crore in FY 2024.
Promoter Shareholding in Titan Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 55.78% in December 2025 to 55.78% in March 2026.
Titan Biotech Ltd delivered a 1-year return of 412.45% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Titan Biotech Ltd share price moved down by 1.33% from its previous close of INR ₹442.40. The latest Titan Biotech Ltd share price is INR ₹436.50.
Titan Biotech Ltd share price today has been at a low of 435 and a high of 449.95. Over the past 52 weeks, the Titan Biotech Ltd share price has seen a low of 74.73 and a high of 555.65.